Pharmaceuticals

Drug Development Clinical Trials Vaccine Development Drug Discovery Clinical Research Drug Delivery Systems Antibiotics Antibody Development Antibiotic Development Weight Loss Drugs

3 ARTICLES

4w ago

Apogee Secures $1.3 Billion Blackstone Package and Selects Mid‑Dose After Positive Phase 2

The company says the deal plus roughly $1.3 billion in cash should fund late‑stage development through potential approval with Blackstone taking tiered royalties on future sales.

6 ARTICLES

last mo.

Roche to Acquire PathAI for $750 Million Upfront Plus Up to $300 Million in Milestones

5 ARTICLES

2mo ago

Regeneron and Telix Form 50/50 Partnership to Develop Targeted Radiopharmaceuticals

5 ARTICLES

2mo ago

Dog Longevity Pill Advances After FDA Safety Check

3 ARTICLES

3mo ago

Mexico Clears Takeda’s Qdenga Dengue Vaccine for Private-Sector Sale

5 ARTICLES

5mo ago

MIT Tests Biodegradable Pill That Signals When It’s Swallowed

3 ARTICLES

5mo ago

Spanish-Led Spinal Cord Implant Project Seeks Investors to Advance Toward Human Trials

5 ARTICLES

6mo ago

MoonLake Immunotherapeutics Investors Face Lead‑Plaintiff Deadline in Securities Fraud Suits

3 ARTICLES

6mo ago

Janux Plunges on Mixed Phase 1 Prostate Cancer Data for JANX007

5 ARTICLES

7mo ago

Polymer Lets Insulin Cross Skin in Animals, Matching Injections in Early Tests

4 ARTICLES

7mo ago

Centessa Prices $250 Million ADS Offering at $21.50 as Shares Hit Record High

5 ARTICLES

7mo ago

Sheffield's M102 Slows Motor Neurone Disease in Mice

6 ARTICLES

7mo ago

Biovac Opens Cape Town Product Development Lab to Advance Africa’s Vaccine Capacity

4 ARTICLES

8mo ago

Biogen Licenses Vanqua’s Preclinical C5aR1 Drug in Deal Worth Up to $1.06 Billion

8 ARTICLES

8mo ago

Russia’s Flu Season Starts Slowly as Hospitalizations Tick Up

3 ARTICLES

8mo ago

Santander Warns of 286% Surge in Weight-Loss Jab Scams Since January

3 ARTICLES

8mo ago

AI-Guided Antibiotic Enterololin Targets Crohn’s-Linked Bacteria

Pharmaceuticals

Apogee Secures $1.3 Billion Blackstone Package and Selects Mid‑Dose After Positive Phase 2

AI-Designed Miniproteins Target GPCRs in Nature Study

NervGen Prices $60 Million Public Offering of Shares and Warrants

Isomorphic Labs Raises $2.1 Billion to Scale AI Drug Design

Roche to Acquire PathAI for $750 Million Upfront Plus Up to $300 Million in Milestones

Regeneron and Telix Form 50/50 Partnership to Develop Targeted Radiopharmaceuticals

Dog Longevity Pill Advances After FDA Safety Check

Mexico Clears Takeda’s Qdenga Dengue Vaccine for Private-Sector Sale

MIT Tests Biodegradable Pill That Signals When It’s Swallowed

Spanish-Led Spinal Cord Implant Project Seeks Investors to Advance Toward Human Trials

Never miss stories about

Pharmaceuticals

MoonLake Immunotherapeutics Investors Face Lead‑Plaintiff Deadline in Securities Fraud Suits

Janux Plunges on Mixed Phase 1 Prostate Cancer Data for JANX007

Polymer Lets Insulin Cross Skin in Animals, Matching Injections in Early Tests

Centessa Prices $250 Million ADS Offering at $21.50 as Shares Hit Record High

Sheffield's M102 Slows Motor Neurone Disease in Mice

Biovac Opens Cape Town Product Development Lab to Advance Africa’s Vaccine Capacity

Biogen Licenses Vanqua’s Preclinical C5aR1 Drug in Deal Worth Up to $1.06 Billion

Russia’s Flu Season Starts Slowly as Hospitalizations Tick Up

Santander Warns of 286% Surge in Weight-Loss Jab Scams Since January

AI-Guided Antibiotic Enterololin Targets Crohn’s-Linked Bacteria

Never miss stories about

Pharmaceuticals